Cognitive and behavioural effects of genetic testing for thrombophilia

Journal of Genetic Counseling

Volumn 17, Issue 3, 2008, Pages 288-296

  Heshka, J ^a   Palleschi, C ^a   Wilson, B ^a   Brehaut, J ^a,b   Rutberg, J ^b   Etchegary, H ^a   Langlois, N ^b   Rodger, M ^a,b   Wells, P S ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Behaviour change; Counseling; Education; Risk perception; Survey; Thrombophilia; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BEHAVIORAL SCIENCE; COGNITION; COMPRESSION GARMENT; CONTROLLED STUDY; DEPRESSION; FEMALE; GENETIC ANALYSIS; GENETIC RISK; HEALTH BEHAVIOR; HEALTH SERVICE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OVEREXERTION; PATIENT ATTITUDE; QUESTIONNAIRE; RISK FACTOR; STRESS; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

COGNITION; CROSS-SECTIONAL STUDIES; GENETIC SCREENING; HUMANS; QUESTIONNAIRES; THROMBOPHILIA;

EID: 44949242467     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-008-9148-1     Document Type: Article

References (13)

1. Baglin, T. (2000). Thrombophilia testing: what do we think the tests mean and what should we do with the results? Journal of Clinical Pathology, 53, 167-170.
2. Bank, I., Scavenius, M. P., Buller, H. R., & Middeldorp, S. (2004). Social aspects of genetic testing for factor V Leiden mutation in health individuals and their importance for daily practice. Thrombosis Research, 113, 7-12.
3. Curran, S. L., Andrykowski, M. A., & Studts, J. L. (1995). Short form of the Profile of Mood States (POMS-SF): Psychometric information. Psychological Assessment, 7, 80-83.
4. Greaves, M., & Baglin, T. (2000). Laboratory testing for heritable thrombophilia: impact on clinical management of thrombotic disease annotation. British Journal of Haematology, 109, 699-703.
5. Hellmann, E. A., Leslie, N. D., & Moll, S. (2003). Knowledge and educational needs of individuals with the factor V Leiden mutation. Journal of Thrombosis and Haemostasis, 1, 2335-2339.
6. Hertzberg, M. S. (2005). Genetic testing for thrombophilia mutations. Seminars in Thrombosis and Hemostasis, 31, 33-38.
7. Lindvist, P. G., & Dahlback, B. (2003). Reactions to awareness of activated protein C resistance carriership: a descriptive study of 270 women. Acta Obstetricia et Gynecologica Scandinavica, 82, 467-470.
8. Little, K., & Penman, E. (1989). Measuring subacute mood changes using the profile of mood states and visual analogue scales. Psychopathology, 22, 42-49.
9. Mannucci, P. M. (2001). Genetic hypercoagulability: prevention suggests testing family members. Blood, 98, 21-22.
10. Middeldorp, S., Meinardi, J. R., Koopman, M. M., van Pampus, E. C., Hamulyak, K., van Der, M. J., et al. (2001). A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism. Annals of Internal Medicine, 135, 322-327.
11. Moss-Morris, R., Weinman, J., Peterie, K. J., Horne, R., Cameron, L. D., & Buick, D. (2002). The revised illness perception questionnaire (IPQ-R). Psychology and Health, 17, 1-16.
12. Sauko, P. M., Richards, S. H., Shepherd, M. H., & Campbell, J. L. (2006). Are genetic tests exceptional? Lessons from a qualitative study on thrombophilia. Social Science & Medicine, 63, 1847-1859.
13. Van Korlaar, I. M., Vossen, C. Y., Rosendaal, F. R., Bovill, E. G., Naud, S., Cameron, L. D., et al. (2005). Attitudes toward genetic testing for thrombophilia in asymptomatic members of a large family with heritable protein C deficiency. Journal of Thrombosis and Haemostasis, 3, 2437-2444.